We are advising Integer on the transaction

Davis Polk is advising Integer Holdings Corporation in connection with its sale to an affiliate of investment funds managed by KKR in an all-cash transaction valued at an enterprise value of approximately $5.7 billion. The transaction is expected to close by the end of 2026, subject to customary closing conditions, including regulatory approvals.

Integer Holdings is one of the largest medical device contract development and manufacturing organizations in the world, serving the cardio and vascular, neuromodulation and cardiac rhythm management markets.

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions.

The Davis Polk corporate team includes partner James P. Dougherty, counsel Joshua B. Pittell and Malik M. Khalil and associates Cameron K. Hood, Junie Khang and Daniel Tublin. Partner Kyoko Takahashi Lin and counsel Joseph S. Brown are providing executive compensation advice. Partners Nathaniel L. Asker and Matthew Yeowart are providing antitrust and competition advice. Members of the Davis Polk team are based in the New York and London offices.